Petach-Tikva, Israel

Alexey Vanichkin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tel Aviv University. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexey Vanichkin: Innovator in Cell Transplantation Techniques

Introduction

Alexey Vanichkin is a notable inventor based in Petach-Tikva, Israel. He has made significant contributions to the field of medical technology, particularly in the area of cell transplantation. His innovative methods aim to enhance the effectiveness of treatments involving cell therapy.

Latest Patents

Vanichkin holds a patent for a groundbreaking method titled "Transplantation of cells into the nasal cavity and the subarachnoid cranial space." This method involves transplanting cells into the paranasal sinus or the subarachnoid cavity located between the frontal bone of the skull and the olfactory bulb. The patent also includes devices designed for these specific transplantation procedures. He has 1 patent to his name.

Career Highlights

Currently, Alexey Vanichkin is affiliated with Tel Aviv University, where he continues to advance his research and development in cell transplantation techniques. His work is pivotal in exploring new avenues for medical treatments that could improve patient outcomes.

Collaborations

Throughout his career, Vanichkin has collaborated with esteemed colleagues, including Konstantin Bloch and Pnina Vardi. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Alexey Vanichkin's contributions to cell transplantation represent a significant advancement in medical technology. His innovative methods and dedication to research continue to pave the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…